- Home
- LPTX vs RVSB Comparison
LPTX vs RVSB Comparison
Compare LPTX & RVSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTX
- RVSB
- Stock Information
- Founded
- LPTX 2011
- RVSB 1923
- Country
- LPTX United States
- RVSB United States
- Employees
- LPTX N/A
- RVSB N/A
- Industry
- LPTX Biotechnology: Biological Products (No Diagnostic Substances)
- RVSB Savings Institutions
- Sector
- LPTX Health Care
- RVSB Finance
- Exchange
- LPTX Nasdaq
- RVSB Nasdaq
- Market Cap
- LPTX 119.6M
- RVSB 122.2M
- IPO Year
- LPTX N/A
- RVSB 1993
- Fundamental
- Price
- LPTX $0.48
- RVSB $5.14
- Analyst Decision
- LPTX Buy
- RVSB
- Analyst Count
- LPTX 3
- RVSB 0
- Target Price
- LPTX $8.50
- RVSB N/A
- AVG Volume (30 Days)
- LPTX 1.5M
- RVSB 34.8K
- Earning Date
- LPTX 03-17-2025
- RVSB 01-30-2025
- Dividend Yield
- LPTX N/A
- RVSB 1.54%
- EPS Growth
- LPTX N/A
- RVSB N/A
- EPS
- LPTX N/A
- RVSB 0.04
- Revenue
- LPTX N/A
- RVSB $46,646,000.00
- Revenue This Year
- LPTX N/A
- RVSB N/A
- Revenue Next Year
- LPTX N/A
- RVSB $13.88
- P/E Ratio
- LPTX N/A
- RVSB $139.08
- Revenue Growth
- LPTX N/A
- RVSB N/A
- 52 Week Low
- LPTX $0.47
- RVSB $3.30
- 52 Week High
- LPTX $4.79
- RVSB $5.89
- Technical
- Relative Strength Index (RSI)
- LPTX 19.00
- RVSB 20.43
- Support Level
- LPTX $0.47
- RVSB $5.30
- Resistance Level
- LPTX $0.53
- RVSB $5.48
- Average True Range (ATR)
- LPTX 0.04
- RVSB 0.10
- MACD
- LPTX 0.07
- RVSB -0.04
- Stochastic Oscillator
- LPTX 7.42
- RVSB 0.00
About LPTX Leap Therapeutics Inc.
Leap Therapeutics Inc is in developing targeted antibody therapies for cancer treatment, focusing on inhibiting tumor-promoting pathways, targeting cancer-specific cell surface molecules, and activating the immune system against cancer cells. The company's lead program, DKN-01, targets Dickkopf-related protein 1 (DKK1) and is in clinical trials for esophagogastric, gynecologic, and colorectal cancers. Their second program, FL-301, targets Claudin18.2-expressing cells. Additionally, the company has two preclinical antibody programs, FL-302 and FL-501, aimed at developing transformative cancer treatments. Operating as a single segment, the company's sole focus is on developing innovative drugs to address unmet needs in cancer therapy. .
About RVSB Riverview Bancorp Inc
Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.